Valuation: RPG Life Sciences Limited

Market Cap 44.47B 468M 406M 380M 348M 656M 665M 4.45B 1.75B 22.26B 1.76B 1.72B 74.12B P/E 2025
20.6x
P/E 2026 26.7x
Enterprise Value 41.93B 441M 383M 358M 328M 618M 627M 4.19B 1.65B 20.99B 1.65B 1.62B 69.88B EV / Sales 2025
5.37x
EV / Sales 2026 3.98x
Free-Float
24.7%
Yield 2025
0.88%
Yield 2026 1.29%
1 day-0.70%
1 week-5.66%
Current month-2.86%
1 month+11.30%
3 months+15.79%
6 months+34.36%
Current year+15.79%
1 week 2,657
Extreme 2657
2,836.9
1 month 2,366.8
Extreme 2366.8
3,082
Current year 1,733
Extreme 1733
3,082
1 year 1,733
Extreme 1733
3,082
3 years 1,100
Extreme 1100
3,082
5 years 450.55
Extreme 450.55
3,082
10 years 142.95
Extreme 142.95
3,082
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2025-12-14
Compliance Officer - 2011-11-10
Director TitleAgeSince
Chairman 68 2008-02-05
Director/Board Member 57 2015-01-22
Director/Board Member 68 2015-12-31
Date Insider Type Main position Quantity % Market Cap.
3/12/25
Nucleus Life Trust
BuyCompany 3,048 0.0184%
3/12/25
Nucleus Life Trust
BuyCompany 1,859 0.0112%
3/12/25
Nucleus Life Trust
BuyCompany 4,412 0.0267%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%-5.66%+15.34%+145.32% 471M
+1.89%-1.49%+55.62%+165.18% 1,043B
-0.24%-3.22%+50.51%+52.02% 621B
-0.95%-7.38%+22.83%+65.08% 435B
0.00%+0.83%+42.80%+37.60% 361B
+0.58%-3.51%+31.12%+40.54% 293B
-1.55%-9.78%+5.61%+8.62% 251B
-0.73%+4.44%+34.91%+66.41% 220B
-0.24%-13.15%-4.02%-44.69% 201B
-0.68%-1.41%+16.36%+66.32% 164B
Average -0.41%-3.93%+27.11%+60.24% 358.96B
Weighted average by Cap. -0.25%-3.79%+37.56%+77.19%

Financials

2025 2026
Net sales 6.53B 68.7M 59.62M 55.79M 51.09M 96.32M 97.72M 653M 256M 3.27B 258M 252M 10.89B 7.08B 74.39M 64.56M 60.41M 55.32M 104M 106M 707M 278M 3.54B 279M 273M 11.79B
Net income 1.83B 19.27M 16.72M 15.65M 14.33M 27.01M 27.4M 183M 71.92M 917M 72.33M 70.76M 3.05B 1.15B 12.11M 10.51M 9.83M 9.01M 16.98M 17.22M 115M 45.2M 577M 45.46M 44.47M 1.92B
Net Debt -2.65B -27.82M -24.14M -22.59M -20.69M -39M -39.57M -264M -104M -1.32B -104M -102M -4.41B -2.54B -26.74M -23.21M -21.72M -19.89M -37.49M -38.04M -254M -99.83M -1.27B -100M -98.22M -4.24B
Logo RPG Life Sciences Limited
RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.
Employees
1,366
Date Price Change Volume
26-08-06 ₹2,688.90 -0.70% 11,038
26-08-05 ₹2,707.80 -1.38% 12,606
26-08-04 ₹2,745.70 -0.40% 8,328
26-08-03 ₹2,756.80 -0.41% 14,650
26-07-31 ₹2,768.20 -0.36% 14,230
  1. Stock Market
  2. Stocks
  3. RPGLIFE Stock